Johnson & Johnson News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

05.10.21	Johnson & Johnson Submits Data To FDA To Support Booster Of Single-Shot COVID-19 Vaccine (RTTNews)
05.10.21	Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine (PR Newswire)
28.09.21	Johnson & Johnson Celebrates COVID-19 Vaccine Science Superheroes (PR Newswire)
21.09.21	J&J: Real-world Data Confirms Efficacy Of Vaccine In The U.S.; Booster Shows 94% Protection (RTTNews)
21.09.21	Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. (PR Newswire)
16.09.21	Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results (PR Newswire)
14.09.21	Johnson & Johnson Ebola Vaccine Data Shows Strong Immune Response (RTTNews)
14.09.21	Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases (PR Newswire)
02.09.21	Battle Against Johnson & Johnson "Texas Two-Step" Ploy Moves to New Jersey (PR Newswire)
01.09.21	FDA OK's Janssen Pharmaceutical's INVEGA HAFYERA To Treat Adults With Schizophrenia - Quick Facts (RTTNews)
31.08.21	Outcry Continues to Grow for Johnson & Johnson to Resolve Talc-Cancer Claims After Latest Jury Verdict (PR Newswire)
31.08.21	Johnson & Johnson: HIV Vaccine Candidate Fails To Provide Protection; To Discontinue Imbokodo Study (RTTNews)
31.08.21	Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa (PR Newswire)
26.08.21	Johnson & Johnson Seeks Global Nominees for Award Geared at Female Researchers Working in Science, Technology, Engineering, Math, Manufacturing and Design (PR Newswire)
26.08.21	Johnson & Johnson to Participate in the Cantor Virtual Global Healthcare Conference (PR Newswire)
25.08.21	J&J COVID-19 Vaccine Booster Dose Rapidly Boosted Spike-binding Antibodies (RTTNews)
25.08.21	Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine (PR Newswire)
24.08.21	Ovarian Cancer Victims Ask Court to Block Johnson & Johnson's 'Texas Two-Step' Bankruptcy Plan (PR Newswire)
20.08.21	Alex Gorsky To Step Down As J&J's CEO And Joaquin Duato To Take Over CEO Role (RTTNews)
19.08.21	Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022 (PR Newswire)
12.08.21	Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference (PR Newswire)
09.08.21	Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference (PR Newswire)
08.08.21	India Approves Johnson & Johnson's Single-dose COVID-19 Vaccine (RTTNews)
29.07.21	Women Cancer Victims Opposed to Johnson & Johnson's 'Texas Two-Step' Bankruptcy Ploy Urge Passage of Reforms Introduced by Warren, Durbin, Nadler, Blumenthal, and Maloney (PR Newswire)
29.07.21	FDA Extends Shelf-life Of Johnson & Johnson's COVID-19 Vaccine (RTTNews)
27.07.21	Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference (PR Newswire)
21.07.21	Johnson & Johnson, Drug Distributors Settle $26 Bln Opioid Deal (RTTNews)
21.07.21	Johnson & Johnson Raises FY21 View Above Market As Q2 Results Top Estimates (RTTNews)
21.07.21	Johnson & Johnson Q2 adjusted earnings Beat Estimates (RTTNews)
21.07.21	Johnson & Johnson Reports Q2 2021 Results (PR Newswire)
20.07.21	Three Drug Distributors To Pay Up To $1.18 Bln To Settle New York Opioid Claims (RTTNews)
19.07.21	Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2021 (PR Newswire)
19.07.21	Johnson & Johnson Considering Plan To Put Talc Liabilities Into Bankruptcy : Report (RTTNews)
15.07.21	Johnson & Johnson Recalls Certain Sunscreen Products Due To Benzene Presence (RTTNews)
14.07.21	Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA® and AVEENO® Aerosol Sunscreen Products Due to the Presence of Benzene (PR Newswire)
13.07.21	J&J, AstraZeneca Exploring Fixes To Rare Blood Clots Linked To Their Vaccines: WSJ (RTTNews)
12.07.21	J&J's Covid Vaccine Linked To Rare Neurological Condition; FDA Might Issue Warning (RTTNews)
09.07.21	Johnson & Johnson Launches Network of Global Health Discovery Centers that Aim to Speed Up Science and Tackle Pandemic Threats (PR Newswire)
02.07.21	J&J Says Data Shows Its Single-shot COVID-19 Vaccine Effective Against Delta And Other Variants (RTTNews)
02.07.21	Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response (PR Newswire)
26.06.21	Johnson & Johnson Agrees To Settle New York Opioid Lawsuit : Reports (RTTNews)
09.06.21	Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results (PR Newswire)
09.06.21	Johnson & Johnson Releases 2020 Health for Humanity Report Highlighting Performance and Progress on Environmental, Social and Governance Priorities (PR Newswire)
07.06.21	Argenx To Regain Global Rights To Anti-CD70 Antibody Cusatuzumab From Janssen's Cilag (RTTNews)
01.06.21	Supreme Court Dismisses J&J Appeal Against The $2bln Fine (RTTNews)
28.05.21	Johnson & Johnson's Single Dose COVID-19 Vaccine Approved In U.K. (RTTNews)
21.05.21	Janssen Gets Two Positive CHMP Opinions For Darzalex Subcutaneous Formulation Utilizing Enhanze (RTTNews)
26.04.21	J&J Vaccine Holds Lower Side Effect Risks Than Aspirin: NIH Director (RTTNews)
26.04.21	FDA Lifts Pause On Johnson & Johnson's COVID-19 Vaccine (RTTNews)
20.04.21	EMA Says J&J Covid Vaccine's Benefits Outweigh Rare Blood Clot Risks (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

09.05.25		Novartis-Aktie: Das sind die Expertenmeinungen des Monats April
09.05.25		Aktienempfehlung: So bewertet Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) die Fresenius SE-Aktie
09.05.25		DAX 40-Wert Bayer-Aktie: So viel Verlust hätte ein Bayer-Investment von vor einem Jahr eingebracht
08.05.25		Nestlé will Wassergeschäft verkaufen - Aktie tiefer
08.05.25		S&P 500-Wert Moderna-Aktie: So viel Verlust hätte ein Investment in Moderna von vor einem Jahr bedeutet
08.05.25		Stoxx Europe 50-Papier GSK-Aktie: Über diese Dividendenzahlung können sich GSK-Anleger freuen
08.05.25		Investment-Note für Fresenius SE-Aktie: Neue Analyse von Barclays Capital
08.05.25		Investment-Tipp: So bewertet Barclays Capital die Fresenius Medical Care (FMC) St-Aktie

09.05.25

Novartis-Aktie: Das sind die Expertenmeinungen des Monats April

09.05.25

Aktienempfehlung: So bewertet Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) die Fresenius SE-Aktie

09.05.25

DAX 40-Wert Bayer-Aktie: So viel Verlust hätte ein Bayer-Investment von vor einem Jahr eingebracht

08.05.25

Nestlé will Wassergeschäft verkaufen - Aktie tiefer

08.05.25

S&P 500-Wert Moderna-Aktie: So viel Verlust hätte ein Investment in Moderna von vor einem Jahr bedeutet

08.05.25

Stoxx Europe 50-Papier GSK-Aktie: Über diese Dividendenzahlung können sich GSK-Anleger freuen

08.05.25

Investment-Note für Fresenius SE-Aktie: Neue Analyse von Barclays Capital

08.05.25

Investment-Tipp: So bewertet Barclays Capital die Fresenius Medical Care (FMC) St-Aktie

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Sonova Hldg	262.10	3.39 %	K V
Lonza Grp	584.80	2.38 %	K V
Logitech Intl	66.76	1.71 %	K V
Part Grp Hldg	1’114.00	1.41 %	K V
Swisscom	544.00	0.74 %	K V
ABB	45.07	0.04 %	K V
Novartis	90.91	-0.22 %	K V
Zurich Insur Gr	581.00	-0.34 %	K V
Roche Hldg G	257.60	-0.88 %	K V
Kuehne+Nagel Int	177.85	-3.24 %	K V

Johnson & Johnson Aktie VALOR 943981 / ISIN US4781601046

Nachrichten zu Johnson & Johnson

Aktien Top/Flop

Johnson & Johnson Peer Group Nachrichten

Meistgelesene Nachrichten